MedLight: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedLight
Largest movements
- Receivables within one year -€3,487
down €3,487 (-81.2%), from €4,292 to €806
of which Trade receivables: -€3,275
- Cash +€2,237
up €2,237 (+76.0%), from €2,945 to €5,182
mainly Receivables within one year (+€3,487) and Other debts (+€3,131)
- Tangible fixed assets +€1,801
new in 2025: €1,801
- Other debts +€3,131
up €3,131 (+5.6%), from €55,996 to €59,128
- Trade debts -€1,692
down €1,692 (-52.7%), from €3,211 to €1,519
- Profit (loss) carried forward -€974
down €974 (-1.7%), from -€56,592 to -€57,566
- Advances received +€116
new in 2025: €116
- Gross operating margin +€4,116
up €4,116, from -€3,861 to €256
- Financial charges -€215
down €215 (-58.4%), from €368 to €153
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,616 | €8,196 | +€581 | +7.6% |
| Fixed assets | 21/28 | - | €1,801 | +€1,801 | |
| Tangible fixed assets | 22/27 | - | €1,801 | +€1,801 | |
| Furniture and vehicles | 24 | - | €1,801 | +€1,801 | |
| Current assets | 29/58 | €7,616 | €6,395 | -€1,221 | -16.0% |
| Amounts receivable within one year | 40/41 | €4,292 | €806 | -€3,487 | -81.2% |
| Trade receivables | 40 | €3,906 | €631 | -€3,275 | -83.8% |
| Other amounts receivable | 41 | €387 | €175 | -€212 | -54.8% |
| Cash at bank and in hand | 54/58 | €2,945 | €5,182 | +€2,237 | +76.0% |
| Deferred charges and accrued income | 490/1 | €379 | €407 | +€29 | +7.6% |
| Total equity and liabilities | 10/49 | €7,616 | €8,196 | +€581 | +7.6% |
| Equity | 10/15 | -€51,592 | -€52,566 | -€974 | -1.9% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€56,592 | -€57,566 | -€974 | -1.7% |
| Amounts payable | 17/49 | €59,207 | €60,762 | +€1,555 | +2.6% |
| Amounts payable within one year | 42/48 | €59,207 | €60,762 | +€1,555 | +2.6% |
| Trade debts | 44 | €3,211 | €1,519 | -€1,692 | -52.7% |
| Suppliers | 440/4 | €3,211 | €1,519 | -€1,692 | -52.7% |
| Advances received on contracts in progress | 46 | - | €116 | +€116 | |
| Other amounts payable | 47/48 | €55,996 | €59,128 | +€3,131 | +5.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €672 | €677 | +€5 | +0.8% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | -€3,861 | €256 | +€4,116 | |
| Operating profit (loss) | 9901 | -€4,920 | -€821 | +€4,099 | +83.3% |
| Financial charges | 65/66B | €368 | €153 | -€215 | -58.4% |
| Recurring financial charges | 65 | €368 | €153 | -€215 | -58.4% |
| Profit (loss) for the period before taxes | 9903 | -€5,288 | -€974 | +€4,314 | +81.6% |
| Profit (loss) for the period | 9904 | -€5,288 | -€974 | +€4,314 | +81.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,288 | -€974 | +€4,314 | +81.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.